|
LOC100190938 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.459400E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.593600E-02 |
| Normal-vs-Stage2 |
7.581400E-01 |
| Normal-vs-Stage3 |
1.423680E-03 |
| Normal-vs-Stage4 |
1.339520E-02 |
| Stage1-vs-Stage2 |
1.222240E-01 |
| Stage1-vs-Stage3 |
3.54380000000543E-05 |
| Stage1-vs-Stage4 |
4.994000E-04 |
| Stage2-vs-Stage3 |
1.432190E-01 |
| Stage2-vs-Stage4 |
1.241760E-01 |
| Stage3-vs-Stage4 |
6.430200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.850590E-01 |
| Normal-vs-AfricanAmerican |
1.627560E-01 |
| Normal-vs-Asian |
2.657800E-01 |
| Caucasian-vs-AfricanAmerican |
1.022950E-01 |
| Caucasian-vs-Asian |
4.428500E-02 |
| AfricanAmerican-vs-Asian |
9.301200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.717580E-01 |
| Normal-vs-Female |
2.422400E-01 |
| Male-vs-Female |
5.248100E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.997200E-01 |
| Normal-vs-Age(41-60Yrs) |
3.949800E-01 |
| Normal-vs-Age(61-80Yrs) |
4.286800E-01 |
| Normal-vs-Age(81-100Yrs) |
1.537640E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.459000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.466800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.260300E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.776830E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.318900E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.365800E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
9.702800E-03 |
| Normal-vs-Grade 2 |
2.649500E-02 |
| Normal-vs-Grade 3 |
1.435190E-01 |
| Normal-vs-Grade 4 |
7.242100E-03 |
| Grade 1-vs-Grade 2 |
4.507600E-02 |
| Grade 1-vs-Grade 3 |
1.821540E-02 |
| Grade 1-vs-Grade 4 |
6.382100E-04 |
| Grade 2-vs-Grade 3 |
3.975000E-03 |
| Grade 2-vs-Grade 4 |
6.26479999999985E-05 |
| Grade 3-vs-Grade 4 |
1.830160E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.620200E-01 |
| Normal-vs-ccB subtype |
6.393600E-02 |
| ccA subtype-vs-ccB subtype |
1.275660E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.423400E-01 |
| Normal-vs-N1 |
7.595600E-03 |
| N0-vs-N1 |
1.581960E-02 |
|
|
